You searched for: mobilisation (Portugisiska - Engelska)

factors for mobilisation of autologous stem cells points to consider on the clinical investigation of new medicinal products for
points to consider concerning endpoints in clinical studies with haematopoietic growth factors for mobilisation of autologous stem cells adopted february 2000

*fonds africain de developpement: etude de mobilisation des eaux dans la region de maradi niger.
*fonds africain de developpement: etude de mobilisation des eaux dans la region de maradi niger.

a organização mundial da saúde oms em parceria com o stop tb lançaram em 2006 a advocacy, communication and social mobilisation acsm, no intuito de conscientizar a população sobre a tb e estimular a participação comunitária no controle da doença.
the world health organization who together with the stop tb strategy created the advocacy, communication and social mobilization acsm in 2006, with the purpose of making the population aware of tb and stimulating community participation in health control.

as recomendações constantes do documento «good practice guidance on the sustainable mobilisation of wood in europe» (de 2010) devem ser tidas em conta.
the recommendations set out in the good practice guidance on the sustainable mobilisation of wood in europe (2010) should be taken into consideration.

emea/mb/050/00 relatório anual 2000 page 85/88 note for guidance on the clinical emea/cpmp/bpwg/198/95 publicado para consulta em junho de investigation of human plasma derived rev.1 2000 factor viii and ix products note for guidance on the clinical publicado para consulta em junho de emea/cpmp/bpwg/1561/99 investigation of recombinant factor viii 2000 and ix products emea/cpmp/phvwp/bpwg/publicado para consulta em junho de core spc for human albumin 2231/99 2000 note for guidance on the clinical publicado para consulta em emea/cpmp/bpwg/2220/99 investigation of plasma derived dezembro de 2000 antithrombin products core spc for human plasma derived publicado para consulta em emea/cpmp/bpwg/3226/99 antithrombin dezembro de 2000 grupo de trabalho " eficácia " do cpmp número de referência linhas de orientação situação note for guidance on clinical investigation emea/cpmp/ewp/519/98 aprovada em fevereiro de 2000 of steroid contraceptives in woman points to consider concerning endpoints in clinical studies with haematopoietic growth emea/cpmp/ewp/197/99 aprovada em fevereiro de 2000 factors for mobilisation of autologous stem cells points to consider on the clinical investigation of new medicinal products for emea/cpmp/ewp/570/98 treatment of acute coronary syndrome aprovada em fevereiro de 2000 (acs) without persistent st-segment elevation concept paper on the development of a cpmp note for guidance on the clinical emea/cpmp/ewp/2922/99 aprovada em fevereiro de 2000 investigation of medicinal products in the treatment of asthma concept paper on the development of a cpmp points to consider on biostatistical/methodological issues arising emea/cpmp/ewp/2863/99 aprovada em fevereiro de 2000 from cpmp discussions on licensing applications: adjustment for baseline covariates points to consider on clinical investigation of medicinal products for prophylaxis of emea/cpmp/ewp/707/98 aprovada em junho de 2000 intra -and post-operative venous thromboembolic risk concept paper on the development of a cpmp note for guidance on the clinical emea/cpmp/ewp/612/00 aprovada em junho de 2000 investigation of medicinal products in pain management points to consider on pharmaco-kinetics emea/cpmp/ewp/2655/99 and pharmacodynamics in the development aprovada em julho de 2000 of anti-bacterial medicinal products points to consider on switching between emea/cpmp/ewp/482/99 aprovada em julho de 2000 superiority and non-inferiority concept paper on the development of a cpmp note for guidance on clinical emea/cpmp/ewp/1080/00 aprovada em julho de 2000 investigation of medicinal products in the treatment of diabetes mellitus points to consider on clinical investigation emea/cpmp/ewp/565/98 of medicinal products for treatment of aprovada em outubro de 2000 amyotrophic lateral sclerosis (als) concept paper on the evaluation of drugs emea/cpmp/ewp/785/97 for the treatment of the irritable bowel aprovada em novembro de 2000 syndrome note for guidance on clinical investigation emea/cpmp/ewp/566/98 rev.
guidelines/status note for guidance on clinical investigation of steroid contraceptives in woman adopted february 2000 points to consider concerning endpoints in clinical studies with haematopoietic growth factors for mobilisation of autologous stem cells adopted february 2000 points to consider on the clinical investigation of new medicinal products for treatment of acute coronary syndrome (acs) without persistent st-segment elevation adopted february 2000 concept paper on the development of a cpmp note for guidance on the clinical investigation of medicinal products in the treatment of asthma adopted february 2000 concept paper on the development of a cpmp points to consider on biostatistical/methodological issues arising from cpmp discussions on licensing applications: adjustment for baseline covariates adopted february 2000 points to consider on clinical investigation of medicinal products for prophylaxis of intra-and post-operative venous thromboembolic risk adopted june 2000 concept paper on the development of a cpmp note for guidance on the clinical investigation of medicinal products in pain management adopted june 2000 points to consider on pharmaco-kinetics and pharmacodynamics in the development of anti-bacterial medicinal products adopted july 2000 points to consider on switching between superiority and non-inferiority adopted july 2000 concept paper on the development of a cpmp note for guidance on clinical investigation of medicinal products in the treatment of diabetes mellitus adopted july 2000 points to consider on clinical investigation of medicinal products for treatment of amyotrophic lateral sclerosis (als) adopted october 2000 concept paper on the evaluation of drugs for the treatment of the irritable bowel syndrome adopted november 2000 note for guidance on clinical investigation of medicinal products in the treatment of epileptic disorders adopted in november 2000 points to consider on clinical investigation of medicinal products for the management of crohn 's disease released for consultation july 2000